Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v5-FR
Language French French
Date Updated 2018-05-02 2017-11-13
Drug Identification Number 02299364 02299364
Brand name RIVA-OXYBUTYNIN RIVA-OXYBUTYNIN
Common or Proper name Oxybutynin 5mg Oxybutynin 5mg
Company Name LABORATOIRE RIVA INC. LABORATOIRE RIVA INC.
Ingredients OXYBUTYNIN CHLORIDE OXYBUTYNIN CHLORIDE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 & 500 100 & 500
ATC code G04BD G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-10-31 2017-10-31
Actual start date 2017-11-08 2017-11-08
Estimated end date 2018-04-20 2017-12-08
Actual end date 2018-04-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments